Vol. 44 | No. 1 | January-June 2016Back

Open Access

Four-Year Clinical Outcomes of Filipino Patients with or at Risk for Atherothrombotic Events from the REACH Registry

Maria Teresa B. Abola, Felix Eduardo R. Punzalan, Artemio A. Roxas
Jun 2016 DOI 10.69944/pjc.c2db87b15a

More Info

Maria Teresa B. Abola, MD; Felix Eduardo R. Punzalan, MD; Artemio A. Roxas, MD 

 

References
  1. World Health Organisation. The top 10 causes of death (2012). Available at: http://www.who.int/mediacentre/factsheets/fs310/en/ index1.html. 
  2. Alberts MJ, Bhatt DL, Mas JL, et al. Three-year follow-up and event rates in the international REduction of Atherothrombosis for Continued Health Registry. Eur Heart J. 2009 Oct; 30(19): 2318–2326. 
  3. Bhatt DL, Eagle KA, Ohman EM, et al. Comparative determinants of 4-year cardiovascular event rates in stable outpatients at risk of or with atherothrombosis. JAMA. 2010 Sep 22;304(12):1350-7. 
  4. Ducrocq G, Bhatt DL, Labreuche J, Corbalan R, et.al. Geographic differences in outcomes in outpatients with established atherothrombotic disease: results from the REACH Registry. Eur J Prev Cardiology. 2014, 21(12):1509-1516. 
  5. Goto S, Ikeda Y, Chan JCN, et.al. Risk-factor profile, drug usage and cardiovascular events within a year in patients with and at high risk of atherothrombosis recruited from Asia as compared with those recruited from non-Asian regions: a substudy of the Reduction of Atherothrombosis for Continued Health (REACH) registry. Heart Asia 2011: 93-98. 
  6. Meadows TA, Bhatt DL, Hirsch AT, Creager MA, et.al. Ethnic differences in the prevalence and treatment of cardiovascular risk factors in US outpatients with peripheral arterial disease: Insights from the Reduction of Atherothrombosis for Continued Health (REACH) Registry. Amer Heart J 2009. 158(6):1038-45. 
  7. Dans, AL, Morales, DD, Velandria, F, Abola TB, et.al. National Nutrition and Health Survey (NNHeS): Atherosclerosis-related Diseases and Risk Factors. Phil J Int Med 2005;43:103-115. 
  8. Sy RG, Morales DD, Dans AL, Paz-Pacheco E, et.al. Prevalence of Atherosclerosis-related risk factors and diseases in the Philippines. J Epidemiol. 2012;22(5):440-7. 
  9. Ohman EM, Bhatt DL, Steg PG, et al. The Reduction of Atherothrombosis for Continued Health (REACH) Registry: an international, prospective, observationalvinvestigation in subjects at risk for atherothrombotic events: study design. Am Heart J. 2006; 151(4):786, e1-e10. 
  10. Bhatt DL, Steg PG, Ohman EM, et al; REACH Registry Investigators. International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. JAMA. 2006;295(2):180-189. 
  11. Steg PG, Bhatt DL, Wilson PW, et al; REACH Registry Investigators. One-year cardiovascular event rates in outpatients with atherothrombosis. JAMA. 2007. 297(11):1197-1206. 
  12. Chiu JF, Bell, AD, Herman RJ, Hill MD, et.al. Cardiovascular risk profiles and outcomes of Chinese living inside and outside China. Eur J Cardiovasc Prev Rehab 2010;17:668-675. 
  13. Food and Nutrition Research Institute and Department of Science and Technology. Burden of Selected Risk Factors to Non communicable diseases among Filipino Adults (8th National Nutritional Survey). Manila: FNRI; 2015. 
  14. Cacoub PP, Abola MT, Baumgartner I, Bhatt, DL, et.al. Cardiovascular risk factor control and outcomes in peripheral artery disease patients in the Reduction of Atherothrombosis for Continued Health (REACH) Registry. Atherosclerosis. 2009 204(2):e86-92.
License

Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License, which permits use, share — copy and redistribute the material in any medium or format, adapt — remix, transform, and build upon the material, as long as you give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use. You may not use the material for commercial purposes. If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original. You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by-nc-sa/4.0/.